ORTHOPEDIATRICS CORP Total Revenue

Quick Answer

ORTHOPEDIATRICS CORP reported Total Revenue of $236.35 million for fiscal year 2025.

ORTHOPEDIATRICS CORP Total Revenue — Annual History

Fiscal Year Total Revenue YoY Change
2025 $236.35M +15.4%
2024 $204.73M +37.6%
2023 $148.73M +21.6%
2022 $122.29M +24.7%
2021 $98.05M +37.9%
2020 $71.08M -2.0%
2019 $72.55M +26.0%
2018 $57.56M +26.2%
2017 $45.62M +22.3%
2016 $37.30M +20.3%
2015 $31.00M

Quarterly Total Revenue

Quarter Ending Total Revenue YoY QoQ
September 30, 2025 $61.25M +12.2% +0.3%
June 30, 2025 $61.08M +15.7% +16.5%
March 31, 2025 $52.41M +17.3% -4.0%
September 30, 2024 $54.57M +36.5% +3.4%
June 30, 2024 $52.80M +33.5% +18.2%
March 31, 2024 $44.69M +41.5% +11.8%
September 30, 2023 $39.97M +14.4% +1.0%
June 30, 2023 $39.56M +20.1% +25.2%
  • ORTHOPEDIATRICS CORP showed an increase of +15.4% in Total Revenue compared to the prior fiscal year.
  • Over the 2015–2025 period, ORTHOPEDIATRICS CORP’s total revenue has grown by 662.3% (from $31.00 million to $236.35 million).
  • The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment